Home/Filings/4/0001209191-18-061990
4//SEC Filing

York Michael 4

Accession 0001209191-18-061990

CIK 0001169245other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:18 PM ET

Size

5.3 KB

Accession

0001209191-18-061990

Insider Transaction Report

Form 4
Period: 2018-12-11
York Michael
VP, Corporate Development
Transactions
  • Purchase

    Common Stock

    2018-12-11$3.88/sh+1,500$5,8201,500 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.81 to $3.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001755422

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:18 PM ET
Size
5.3 KB